IN-DATE
FEM07040: Bard Fluency Plus Endovascular Stent Graft: 7mm x 40mm, 80cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $1,999.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 08-2026 |
| Express: | Need it tomorrow? Order in next 8 hours 29 minutes and choose overnight shipping at checkout. |
Related Items
QUICK VIEW
| VBJR070502A - Size: 7.00mm $1,999.00 per box of 1 Gore Viabahn Endoprosthesis with Heparin: 7mm x 5cm x 120cm Exp: 02-2027 Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| VBCR070502A - Size: 7.00mm $1,999.00 per box of 1 Gore Viabahn Endoprosthesis w/Radiopaque Markers: 7mm x 5cm x 120cm Exp: 01-2027 Units in stock: 1 box of 1 | Order Qty |
QUICK VIEW
| VBCR070501A - Size: 7.00mm $1,995.00 EACH Gore Viabahn Endoprosthesis Radiopaque Markers: 7mm x 5cm, 75cm (No Box) Exp: 11-2026 Units in stock: 1 | Order Qty |
|
QUICK VIEW
| VBHR070502A - Size: 7.00mm $1,999.00 $1,499.25 per box of 1 Gore Viabahn Endoprosthesis with Heparin & Radiopaque Markers: 7mm x 5cm, 120cm Exp: 09-2026 Units in stock: 1 box of 1 | Order Qty |
Additional Details
BD Bard Fluency® Plus Endovascular Stent Graft
- A broad range of implant diameters and lengths for the treatment of in-stent restenotic peripheral and central lesions in patients with AV grafts and AV fistulae
- Small incremental stent graft lengths to help maintain venous real estate and cannulation area
- Minimal shortening and radiopaque markers aid in excellent placement accuracy
AccessGUDID Info
- FDA Product Code: PFV
- FDA Product Code Name: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
- GMDN Term Code: 61856
- GMDN Term Name: Central/peripheral venous endovascular stent-graft
- GMDN Term Description: A non-bioabsorbable tubular device designed to be implanted in a central and/or peripheral vein (e.g., subclavian, brachiocephalic) to maintain vessel lumen patency, typically to treat stenosis in the outflow of an arteriovenous fistula (AVF) or graft used for haemodialysis; it is not intended for coronary or intracranial venous stenting. It is a mesh structure made of metal [e.g., nickel-titanium alloy] that is covered with a synthetic polymer [e.g., polytetrafluoroethylene (ePTFE)] membrane (endovascular graft), and contains an inner carbon coating to help prevent platelet adhesion. It is typically expanded in situ and disposable devices associated with implantation may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
